» Authors » Anneloes van Krimpen

Anneloes van Krimpen

Explore the profile of Anneloes van Krimpen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 42
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Olsthoorn S, van Krimpen A, Hendriks R, Stadhouders R
Immunol Rev . 2025 Feb; 330(1):e70010. PMID: 40016948
Asthma is a common chronic inflammatory disease of the airways. A substantial number of patients present with severe and therapy-resistant asthma, for which the underlying biological mechanisms remain poorly understood....
2.
Tondeur E, Voerman J, Geleijnse M, van Hofwegen L, van Krimpen A, Koerner J, et al.
J Immunol . 2023 Aug; 211(8):1203-1215. PMID: 37638825
The induction of CTL responses by vaccines is important to combat infectious diseases and cancer. Biodegradable poly(lactic-co-glycolic acid) (PLGA) microspheres and synthetic long peptides are efficiently internalized by professional APCs...
3.
van Gulijk M, van Krimpen A, Schetters S, Eterman M, van Elsas M, Mankor J, et al.
Sci Immunol . 2023 May; 8(83):eabn6173. PMID: 37205768
Despite the clinical success of immune checkpoint blockade (ICB), in certain cancer types, most patients with cancer do not respond well. Furthermore, in patients for whom ICB is initially successful,...
4.
van t Land F, Lau S, de Koning W, Klaase L, Vink M, van Krimpen A, et al.
Cancers (Basel) . 2022 Nov; 14(21). PMID: 36358718
Background: Patients with locally advanced pancreatic cancer (LAPC) are treated with chemotherapy. In selected cases, stereotactic body radiotherapy (SBRT) can be added to the regimen. We hypothesized that adding an...
5.
van Krimpen A, Gerretsen V, Mulder E, van Gulijk M, van den Bosch T, Von Der Thusen J, et al.
Cancer Cell . 2022 Jul; 40(8):798-799. PMID: 35839777
No abstract available.